neoantigen vaccine (University of California San Francisco/Kite Pharma)

N/A

Report date: 2025/03/20 14:52:00

Base Information

Drug Nameneoantigen vaccine (University of California San Francisco/Kite Pharma)
Drug Alias Nameneoantigen vaccine (University of California San Francisco)neoantigen vaccine (University of California San Francisco/Tmunity)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionHuman leukocyte antigen modulators
TargetsHuman leukocyte antigen
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California San Francisco
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San FranciscoKite Pharma Inc
Inactive CompaniesTmunity Therapeutics Inc
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A